Safety and Efficacy of CKDB-501A in Subjects With Post-stroke Upper Limb Spasticity
Clinical trial NCT05382767 · COMPLETED
Trial details
- NCT number
- NCT05382767
- Sponsor
- CKD Bio Corporation
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-02
- Primary completion
- 2022-12-08
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.